Skip to content

Järve Apteegid OÜ

Registry code (registrikood) 14916257Private limited company (Osaühing)VAT EE102241330Activity (EMTAK 47731): Ravimite jaemüükActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q3

Revenue (2025)
€4.7M
▲ 3.7% vs 2024
Profit before tax (2025)
-€110k
Employees, FTE (2025)
20
State taxes paid, last 4 quarters
€348k

Revenue, profit and employees, 2020–2025

€2.7M2020€4.1M2021€4.2M2022€3.6M2023€4.5M2024€4.7M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2020€2,679,907€2,340€2,354€4,85422
2021€4,060,442€34,568€34,584€39,43723
2022€4,226,272-€77,132-€77,116-€37,67927
2023€3,600,714-€250,861-€250,853-€288,53219
2024€4,503,455-€196,284-€196,279-€484,81220
2025€4,668,253-€110,028-€110,017-€594,82820

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2020€102,185€536,514€531,660—€4,854
2021€61,693€533,446€494,009—€39,437
2022€157,699€690,683€728,362—-€37,679
2023€97,752€682,057€970,589—-€288,532
2024€82,858€691,975€1,176,787—-€484,812
2025€121,862€803,400€1,398,228—-€594,828

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€74,512€56,380€1,193,48023
2022 Q2€77,441€61,913€1,191,44024
2022 Q3€70,225€66,954€978,51124
2022 Q4€69,981€63,818€1,121,64924
2023 Q1€79,143€67,406€1,127,81421
2023 Q2€62,268€62,263€760,00021
2023 Q3€55,902€55,131€842,25121
2023 Q4€67,399€62,049€1,162,66124
2024 Q1€81,632€71,132€1,176,11024
2024 Q2€73,348€70,112€1,243,01024
2024 Q3€82,419€73,488€1,075,45924
2024 Q4€79,079€71,962€1,326,57725
2025 Q1€87,318€76,158€1,297,03424
2025 Q2€89,425€75,971€1,323,38024
2025 Q3€88,636€75,766€1,119,97524
2025 Q4€91,434€79,208€1,329,83824
2026 Q1€92,659€73,488€1,384,04524
2026 Q2€79,380€73,760€1,391,20724
2026 Q3€84,950€77,761€1,304,57224

Source: EMTA quarterly published data, as of 10 October 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), Järve Apteegid OÜ reported revenue of €4,668,253.

The company recorded a net loss of €110,017 in the 2025 financial year.

Revenue increased by 3.7% from €4,503,455 in 2024 to €4,668,253 in 2025.

Revenue grew at a compound annual rate of 11.7% between 2020 and 2025.

Equity accounted for -74.0% of total assets of €803,400 at the end of the 2025 reporting period.

With 20 full-time-equivalent employees in 2025, revenue per employee was €233,413.

Across the 4 most recent quarters declared to EMTA, up to Q3 2026, Järve Apteegid OÜ reported €5,409,662 in turnover.

EMTA recorded 24 employees for the quarter ending Q3 2026, compared with 20 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-11-16. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.